2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Buy
65
USAC Quote, Financials, Valuation and Earnings
Last price:
$25.22
Seasonality move
:
-0.64%
Day range:
$25.19 - $25.77
52-week range:
$21.06 - $30.10
Dividend yield:
8.33%
P/E ratio:
37.06x
P/S ratio:
3.08x
P/B ratio:
97.85x
Volume:
1.4M
Avg. volume:
222.5K
1-year change:
4.52%
Market cap:
$3B
Revenue:
$950.4M
EPS (TTM):
$0.68
Analysts' Opinion
-
Consensus RatingUSA Compression Partners LP has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.50, USA Compression Partners LP has an estimated upside of 5.16% from its current price of $25.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 100% downside risk from its current price of $25.20.
Fair Value
-
According to the consensus of 4 analysts, USA Compression Partners LP has 5.16% upside to fair value with a price target of $26.50 per share.
USAC vs. S&P 500
-
Over the past 5 trading days, USA Compression Partners LP has overperformed the S&P 500 by 0.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
USA Compression Partners LP does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
USA Compression Partners LP has grown year-over-year revenues for 14 quarters straight. In the most recent quarter USA Compression Partners LP reported revenues of $245.2M.
Earnings Growth
-
USA Compression Partners LP earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter USA Compression Partners LP reported earnings per share of $0.14.
Enterprise value:
5.5B
EV / Invested capital:
2.17x
Price / LTM sales:
3.08x
EV / EBIT:
18.71x
EV / Revenue:
5.69x
PEG ratio (5yr expected):
0.56x
EV / Free cash flow:
26.77x
Price / Operating cash flow:
14.49x
Enterprise value / EBITDA:
9.72x
Gross Profit (TTM):
$375.2M
Return On Assets:
3.48%
Net Income Margin (TTM):
9.99%
Return On Equity:
147.63%
Return On Invested Capital:
3.86%
Operating Margin:
30.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $738.3M | $878.3M | $966.4M | $229.3M | $245.2M | |
| Gross Profit | $253.9M | $335.4M | $375.2M | $91M | $93.2M | |
| Operating Income | $188.8M | $258.9M | $306.5M | $68.1M | $74.4M | |
| EBITDA | $422.4M | $509M | $565.9M | $134M | $139.8M | |
| Diluted EPS | -$0.11 | $0.41 | $0.68 | $0.19 | $0.14 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $204.3M | $211.7M | $185.9M | $248.8M | $243.3M | |
| Total Assets | $2.9B | $2.7B | $2.7B | $2.8B | $2.7B | |
| Current Liabilities | $150M | $167.1M | $156M | $173.7M | $166M | |
| Total Liabilities | $2.1B | $2.2B | $2.3B | $2.7B | $2.7B | |
| Total Equity | $753.1M | $518.9M | $308.8M | $141.8M | -$11.9M | |
| Total Debt | $2B | $2B | $2.2B | $2.5B | $2.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $267.9M | $295.5M | $330.1M | $65.9M | $54.7M | |
| Cash From Investing | -$151.1M | -$290.4M | -$121.5M | -$98.6M | -$18M | |
| Cash From Financing | -$116.8M | -$5.1M | -$208.6M | $32.7M | -$36.6M | |
| Free Cash Flow | $112.5M | -$274K | $205.5M | -$32.7M | $36.3M | |
USAC
Sector
Market Cap
$3B
$58.5M
Price % of 52-Week High
83.72%
61.77%
Dividend Yield
8.33%
0%
Shareholder Yield
--
4.64%
1-Year Price Total Return
4.52%
-29.12%
Beta (5-Year)
0.532
0.672
Dividend yield:
8.33%
Annualized payout:
$2.10
Payout ratio:
275.76%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$25.17
200-day SMA
Buy
Level
$24.18
Bollinger Bands (100)
Sell
Level
24.12 - 27.32
Chaikin Money Flow
Sell
Level
-24.8M
20-day SMA
Buy
Level
$24.51
Relative Strength Index (RSI14)
Buy
Level
53.80
ADX Line
Buy
Level
14.94
Williams %R
Neutral
Level
-35.8566
50-day SMA
Buy
Level
$25.06
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
16M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.1395)
Buy
Beneish M-Score
(Annual)
Level (-3.0295)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.7478)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.
Stock Forecast FAQ
In the current month, USAC has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The USAC average analyst price target in the past 3 months is $26.50.
-
Where Will USA Compression Partners LP Stock Be In 1 Year?
According to analysts, the consensus estimate is that USA Compression Partners LP share price will rise to $26.50 per share over the next 12 months.
-
What Do Analysts Say About USA Compression Partners LP?
Analysts are divided on their view about USA Compression Partners LP share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that USA Compression Partners LP is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is USA Compression Partners LP's Price Target?
The price target for USA Compression Partners LP over the next 1-year time period is forecast to be $26.50 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is USAC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for USA Compression Partners LP is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of USAC?
You can purchase shares of USA Compression Partners LP via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase USA Compression Partners LP shares.
-
What Is The USA Compression Partners LP Share Price Today?
USA Compression Partners LP was last trading at $25.22 per share. This represents the most recent stock quote for USA Compression Partners LP. Yesterday, USA Compression Partners LP closed at $25.20 per share.
-
How To Buy USA Compression Partners LP Stock Online?
In order to purchase USA Compression Partners LP stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
